S&P 500   3,989.57 (+0.47%)
DOW   32,510.05 (+0.85%)
QQQ   308.79 (-0.68%)
AAPL   158.46 (-1.12%)
MSFT   276.51 (-1.45%)
META   202.13 (-1.88%)
GOOGL   102.59 (-2.70%)
AMZN   97.44 (-0.70%)
TSLA   191.50 (+0.57%)
NVDA   265.84 (-0.73%)
NIO   8.92 (-1.65%)
BABA   85.66 (-1.43%)
AMD   96.36 (-1.62%)
T   18.92 (+1.67%)
F   11.52 (+0.09%)
MU   60.08 (-1.77%)
CGC   1.89 (-0.79%)
GE   93.31 (+2.12%)
DIS   95.24 (+1.23%)
AMC   4.40 (-1.57%)
PFE   40.36 (-0.07%)
PYPL   73.56 (-0.43%)
NFLX   325.74 (-0.81%)
S&P 500   3,989.57 (+0.47%)
DOW   32,510.05 (+0.85%)
QQQ   308.79 (-0.68%)
AAPL   158.46 (-1.12%)
MSFT   276.51 (-1.45%)
META   202.13 (-1.88%)
GOOGL   102.59 (-2.70%)
AMZN   97.44 (-0.70%)
TSLA   191.50 (+0.57%)
NVDA   265.84 (-0.73%)
NIO   8.92 (-1.65%)
BABA   85.66 (-1.43%)
AMD   96.36 (-1.62%)
T   18.92 (+1.67%)
F   11.52 (+0.09%)
MU   60.08 (-1.77%)
CGC   1.89 (-0.79%)
GE   93.31 (+2.12%)
DIS   95.24 (+1.23%)
AMC   4.40 (-1.57%)
PFE   40.36 (-0.07%)
PYPL   73.56 (-0.43%)
NFLX   325.74 (-0.81%)
S&P 500   3,989.57 (+0.47%)
DOW   32,510.05 (+0.85%)
QQQ   308.79 (-0.68%)
AAPL   158.46 (-1.12%)
MSFT   276.51 (-1.45%)
META   202.13 (-1.88%)
GOOGL   102.59 (-2.70%)
AMZN   97.44 (-0.70%)
TSLA   191.50 (+0.57%)
NVDA   265.84 (-0.73%)
NIO   8.92 (-1.65%)
BABA   85.66 (-1.43%)
AMD   96.36 (-1.62%)
T   18.92 (+1.67%)
F   11.52 (+0.09%)
MU   60.08 (-1.77%)
CGC   1.89 (-0.79%)
GE   93.31 (+2.12%)
DIS   95.24 (+1.23%)
AMC   4.40 (-1.57%)
PFE   40.36 (-0.07%)
PYPL   73.56 (-0.43%)
NFLX   325.74 (-0.81%)
S&P 500   3,989.57 (+0.47%)
DOW   32,510.05 (+0.85%)
QQQ   308.79 (-0.68%)
AAPL   158.46 (-1.12%)
MSFT   276.51 (-1.45%)
META   202.13 (-1.88%)
GOOGL   102.59 (-2.70%)
AMZN   97.44 (-0.70%)
TSLA   191.50 (+0.57%)
NVDA   265.84 (-0.73%)
NIO   8.92 (-1.65%)
BABA   85.66 (-1.43%)
AMD   96.36 (-1.62%)
T   18.92 (+1.67%)
F   11.52 (+0.09%)
MU   60.08 (-1.77%)
CGC   1.89 (-0.79%)
GE   93.31 (+2.12%)
DIS   95.24 (+1.23%)
AMC   4.40 (-1.57%)
PFE   40.36 (-0.07%)
PYPL   73.56 (-0.43%)
NFLX   325.74 (-0.81%)
Positive News Sentiment  
NASDAQ:ENLV

Enlivex Therapeutics - ENLV Earnings Date, Estimates & Call Transcripts

$3.58
+0.01 (+0.28%)
(As of 03/27/2023 10:02 AM ET)
Add
Compare
Today's Range
$3.58
▼
$3.58
50-Day Range
$3.55
▼
$4.55
52-Week Range
$3.42
▼
$8.64
Volume
1,531 shs
Average Volume
24,766 shs
Market Capitalization
$65.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ENLV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENLV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enlivex Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.35)($0.35)($0.35)
Q4 20231($0.42)($0.42)($0.42)

ENLV Earnings Date and Information

Enlivex Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 5th, 2023 based off prior year's report dates.

Enlivex Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/5/2023
(Estimated)		        
12/5/2022Q3 2022($0.29)($0.31)($0.02)($0.31)
8/22/2022Q2 2022($0.45)($0.54)($0.09)($0.54)
5/27/2022Q1 2022($0.41)($0.45)($0.04)($0.45)
4/29/2022Q4 2021($0.26)($0.26)($0.26)    
11/21/2021Q3($0.21)($0.19)+$0.02($0.19)
8/9/2021Q2 2021($0.26)($0.17)+$0.09($0.17)
6/1/2021Q1 2021($0.21)($0.19)+$0.02($0.19)
4/30/2021Q4 2020($0.43)($0.43)($0.43)
10/30/2020Q3 2020($0.18)($0.16)+$0.02($0.16)
8/14/2020Q2 2020($0.24)($0.23)+$0.01($0.23)
5/18/2020Q1 2020($0.24)($0.07)+$0.17($0.07)
4/30/2020Q4 2019($0.28)($0.28)($0.28)
11/14/2019Q3 2019($0.23)($0.23)($0.23)
7/26/2019Q2 2019($0.14)($0.14)($0.14)
5/20/2019Q1 2019($0.74)($0.74)($0.74)
4/23/2018Q4 2017($1.36)($1.36)($1.36)
11/2/2017Q3 2017($2.56)($2.56)($2.56)
8/4/2017Q2 2017($4.00)($4.00)($4.00)
5/26/2017Q1 2017($11.60)($6.40)+$5.20($6.40)
2/24/2017Q4 2016($10.80)($7.60)+$3.20($7.60)
11/29/2016Q3 2016($10.40)($11.20)($0.80)($11.20)
8/25/2016Q2 2016($10.80)($8.80)+$2.00($8.80)
5/25/2016Q1 2016($11.60)$12.80+$24.40$12.80
2/23/2016Q4 2015($10.00)($13.60)($3.60)($13.60)
11/17/2015Q3 2015($11.60)($10.00)+$1.60($10.00)
8/21/2015Q2 2015($11.20)($10.40)+$0.80($10.40)
5/19/2015Q1 2015($10.00)($9.20)+$0.80($9.20)
2/17/2015Q4 2014($6.40)($8.80)($2.40)($8.80)
11/21/2014Q3 2014($2.00)($6.40)($4.40)($6.40)
8/29/2014Q2 2014($4.00)($4.00)($4.00)












Enlivex Therapeutics Earnings - Frequently Asked Questions

When is Enlivex Therapeutics's earnings date?

Enlivex Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 5th, 2023 based off last year's report dates. Learn more on ENLV's earnings history.

How much profit does Enlivex Therapeutics generate each year?

Enlivex Therapeutics (NASDAQ:ENLV) has a recorded net income of -$14.47 million. ENLV has generated -$1.56 earnings per share over the last four quarters.

What is Enlivex Therapeutics's EPS forecast for next year?

Enlivex Therapeutics's earnings are expected to grow from ($1.68) per share to ($1.55) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:ENLV) was last updated on 3/27/2023 by MarketBeat.com Staff